Fig. 2From: The use of digital outcome measures in clinical trials in rare neurological diseases: a systematic literature reviewNumbers and placements of wearable and portable inertial sensors. Abbreviation: Duchenne Muscular Dystrophy (DMD), Amyotrophic Lateral Sclerosis (ALS), Charcot-Marie-Tooth (CMT), Myotonic Dystrophic (DM), Facioscapulohumeral dystrophy (FSHD), Myasthenia Gravis (MG), Spinal Muscular Atrophy (SMA), Spinal and bulbar muscular atrophy (SBMA), Huntington Disease (HD), Progressive supranuclear palsy (PSP), focal dystonia (FD), Spinocerebellar ataxias (SCA), Hereditary spastic paraplegia (HSP), Fragile X Syndrome (FXS), Friedreich’s ataxia (FRDA), Prader–Willi syndrome (PWS), mucopolysaccharidosis (MPS), GM2 gangliosidosis (GM2), Niemann–Pick type C (NP-C), Tuberous sclerosis complex (TSC)Back to article page